Danish biopharma Orphazyme A/S (ORPH) has priced 7.6M ADS at $11, below the previous expected price of $13.13/ADS.
At pricing, the company raised -16% less in proceeds than anticipated.
https://seekingalpha.com/news/3618022-orphazyme-s-raised-84m-in-ipo
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.